Tirofiban Noninferior to Abciximab: SES Show Sustained Efficacy in Reducing TVR

Summary

This article discusses long-term results from the MULTIcentre evaluation of Single high-dose bolus TiRofiban versus Abciximab with sirolimus-eluting sTEnt or Bare Metal Stent in Acute Myocardial Infarction study [MULTI STRATEGY; NCT00229515].

  • Interventional Techniques & Devices Myocardial Infarction
View Full Text